Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.

被引：0
|
作者：
Kearney, A. Aileen [1 ]
Hill, L. [1 ]
Davidson, J. [1 ]
Mc Clure, C. [1 ]
Dixon, L. [1 ]
机构：
[1] Royal Victoria Hosp, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1662
引用
收藏
页码：411 / 411
页数：1
相关论文
共 50 条
  • [41] Real-Life Indications to Sacubitril/Valsartan Treatment in Patients With Chronic Systolic Heart Failure
    Pinto, Giuseppe
    Tondi, Lara
    Gemma, Marco
    De Marco, Alessandro
    Silipigni, Carmen
    Spoladore, Roberto
    Margonato, Alberto
    Fragasso, Gabriele
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 73 (05) : 301 - 306
  • [42] Valsartan/Sacubitril in Pediatric Heart Failure
    Kemna, M.
    Hong, B.
    Friedland-Little, J.
    Albers, E.
    Law, Y. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S450 - S450
  • [43] Sacubitril-Valsartan in Heart Failure
    Vitting, Kevin E.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (09) : 680 - 680
  • [44] Sacubitril/Valsartan (Entresto) for Heart Failure
    Cheng, Judy
    AMERICAN FAMILY PHYSICIAN, 2016, 94 (08) : 611 - 612
  • [45] Sacubitril/Valsartan (Entresto) for Heart Failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1474): : 107 - 109
  • [46] Sacubitril/Valsartan (Entresto) for Heart Failure
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (07): : 722 - 723
  • [47] The PARASAIL study-Patient Reported Outcomes from the Canadian Real World Experience use of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction
    Haddad, Haissam
    Bergeron, Sebastien
    Ignaszewski, Andrew
    Searles, Gregory
    Rochdi, Driss
    Bastien, Natacha
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S55 - S56
  • [48] Sacubitril/Valsartan: From Clinical Trials to Real-world Experience
    Joly J.M.
    Desai A.S.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (6)
  • [49] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF SYMPTOMATIC CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL
    Alarcao, J.
    Ascencao, R.
    Costa, J.
    Gouveia, M.
    Borges, M.
    VALUE IN HEALTH, 2018, 21 : S104 - S104
  • [50] Safety of sacubitril/valsartan in heart failure outpatients with chronic heart failure in real life in Europe: results from ARIADNE registry
    Zeymer, U.
    Lunde, L. H.
    Barrios, V
    Fonseca, C.
    Clark, A. L.
    Damy, T.
    Drozdz, J.
    Kalus, S.
    Koch, C.
    Maggioni, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1062 - 1062
12345